These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16625159)

  • 1. Drugs tests on trial.
    Nature; 2006 Apr; 440(7087):970. PubMed ID: 16625159
    [No Abstract]   [Full Text] [Related]  

  • 2. Drive for drugs leads to baby clinical trials.
    Nature; 2006 Mar; 440(7083):406-7. PubMed ID: 16554774
    [No Abstract]   [Full Text] [Related]  

  • 3. London's disastrous drug trial has serious side effects for research.
    Wadman M
    Nature; 2006 Mar; 440(7083):388-9. PubMed ID: 16554763
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA to vet embryonic stem cells' safety.
    Baker M
    Nature; 2008 Apr; 452(7188):670. PubMed ID: 18401364
    [No Abstract]   [Full Text] [Related]  

  • 5. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA penalizes trial misconduct.
    Shaffer C
    Nat Biotechnol; 2009 Oct; 27(10):872. PubMed ID: 19816424
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety panel backs principle of gene-therapy trials.
    Check E
    Nature; 2002 Dec; 420(6916):595. PubMed ID: 12478252
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials on trial.
    Nature; 2008 May; 453(7194):427-8. PubMed ID: 18497763
    [No Abstract]   [Full Text] [Related]  

  • 9. Can super-antibody drugs be tamed?
    Nature; 2006 Apr; 440(7086):855-6. PubMed ID: 16612349
    [No Abstract]   [Full Text] [Related]  

  • 10. Missing results might have rung warning bell over trial drug.
    Pearson H
    Nature; 2006 Oct; 443(7113):730-1. PubMed ID: 17051171
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA panel recommends easing gene therapy trial limits.
    Fox JL
    Nat Biotechnol; 2003 Apr; 21(4):344-5. PubMed ID: 12665806
    [No Abstract]   [Full Text] [Related]  

  • 12. Trial deaths prompt tighter rules.
    Macilwain C
    Nature; 1993 Nov; 366(6453):294. PubMed ID: 8247116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Side effects of a desastrous clinical trial].
    Gilgenkrantz S
    Med Sci (Paris); 2006 May; 22(5):557-8. PubMed ID: 16687128
    [No Abstract]   [Full Text] [Related]  

  • 14. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA insists on more women in drug trials.
    Josefson D
    BMJ; 1997 Oct; 315(7112):833. PubMed ID: 9353497
    [No Abstract]   [Full Text] [Related]  

  • 16. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 17. Natalizumab (Tysabri) returns.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289
    [No Abstract]   [Full Text] [Related]  

  • 18. Safeguarding clinical trials.
    Nat Med; 2007 Feb; 13(2):107. PubMed ID: 17290249
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 20. Open clinical trials.
    Drazen JM; Morrissey S; Curfman GD
    N Engl J Med; 2007 Oct; 357(17):1756-7. PubMed ID: 17914035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.